Concentrated Pharma Exposure or Broader Global Healthcare? PPH vs. IXJ
The VanEck Pharmaceutical ETF (PPH) gives investors a concentrated way to own major drugmakers, while the iShares Global Healthcare ETF (IXJ) spreads exposure across the wider healthcare sector. The choice comes down to whether to lean into pharma-driven returns or take a broader approach to global healthcare.
Overview
VanEck Pharmaceutical ETF (NASDAQ:PPH) provides concentrated exposure to global drugmakers, while iShares Global Healthcare ETF (NYSEMKT:IXJ) offers broader access to the wider healthcare sector, including equipment and services companies.
Investors seeking healthcare exposure must choose between targeted pharmaceutical plays and diversified global baskets. This comparison evaluates a focused pharmaceutical fund against a massive, global healthcare giant to determine which better aligns with specific portfolio objectives and risk tolerances.
Details
Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.
Source
Originally published at www.fool.com.